Led by OrbiMed, with participation from RA Capital Management, Janus Henderson Investors, Sanofi Ventures, Harbour BioMed, ...

Three years after AbbVie stood at the edge of a major patent cliff with the loss of exclusivity for immunology ...

Johns Hopkins University has established a Planning Committee for Immunology, a first step toward creating a new interdivisional entity to advance research in the field. Immunology is a branch of ...

At the moment, an influenza vaccine called FluMist is the only licensed intranasal vaccine approved for use in humans. The ...

AbbVie Inc. ABBV on Wednesday reported first-quarter 2026 sales of $15.00 billion, beating the consensus of $14.72 billion.

AbbVie raised its full-year adjusted earnings guidance and reported higher first-quarter revenue, boosted by growth in its ...

Deal builds upon UCB’s position as a leader in immunology innovation and expands capabilities in next-generation biologics ...

The Department of Molecular Microbiology and Immunology (MMI) at Saint Louis University’s School of Medicine offers a Ph.D. program in molecular and cellular virology and immunology. The program ...

Immunology can feel overwhelming with its dense terminology, intricate pathways, and endless cell types—but it doesn’t have to be. From active learning strategies to clever mnemonics and AI-powered ...

Just as pathogens can infect bodies, spread to other bodies and make us sick, bad ideas can infect our minds, spread to other minds and disrupt our thinking. Minds can fall prey to infectious and ...

Nettey was early in his MD-PhD training in immunology in the Harvard-MIT Program in Health Sciences and Technology (HST) when ...

Immunology is a rapidly advancing field with significant potential for growth, especially in the realm of biotech and pharmaceutical companies. As the global demand for innovative treatments for ...